Imperial College London
Alternate

Dr Tini Garske

Faculty of Medicine, School of Public Health

Senior Lecturer
 
 
 
//

Contact

 

t.garske Website

 
 
//

Location

 

410School of Public HealthWhite City Campus

//

Summary

 

Publications

Citation

BibTex format

@article{Ozawa:2020:10.2471/BLT.16.178475,
author = {Ozawa, S and Clark, S and Portnoy, A and Grewal, S and Stack, ML and Sinha, A and Mirelman, A and Franklin, H and Friberg, IK and Tam, Y and Walker, N and Clark, A and Ferrari, M and Suraratdecha, C and Sweet, S and Goldie, SJ and Garske, T and Li, M and Hansen, PM and Johnson, HL and Walker, D},
doi = {10.2471/BLT.16.178475},
journal = {Bulletin of the World Health Organization},
pages = {629--638},
title = {Economic impact of vaccination against 10 vaccinepreventable diseases across 73 low and middleincome countries supported by Gavi, 20012020},
url = {http://dx.doi.org/10.2471/BLT.16.178475},
volume = {95},
year = {2020}
}
Download

RIS format (EndNote, RefMan)

TY  - JOUR
AB  - Objective: To estimate the economic impact achieved by global effortsto accelerate the introduction of new vaccines and increaseimmunization coverage in 73 lowand middleincome countries (LMICs)in the two decades following the launch of Gavi, the Vaccine Alliance(20012020).Methods: Based on relevant health impact models, we assessed theeconomic impact of achieving forecastedimmunizationcoverageforvaccinationagainsttenvaccinepreventablediseases:Haemophilusinfluenzaetypeb,hepatitisB,humanpapillomavirus,Japaneseencephalitis,measles,NeisseriameningitidisserogroupA,rotavirus,rubella,Streptococcuspneumoniae,andyellowfever.Wemodeledavertedtreatmentcosts,transportationcosts,productivitylossofcaregivers,andproductivitylossduetodisabilityanddeathcomparedtonovaccination.Thevalueoflifeyearmethodestimatedtheeconomicandsocialvalueoflivinglongerinbetterhealthasaresultofimmunization.FindingsVaccinationisestimatedtoavertover20milliondeathsandsave$350billionincostofillnessover20012020in73countries.Morethanhalfofthesebenefits($250billion)resultfromvaccinationinthecurrentdecade(20112020).Lifetimeproductivitygainsfrompreventingdeathsanddisabilityareprojectedat$330billionand$9billion,respectively.Immunizationovertheentire20yearperiodisestimatedtopreventnearly$5billionintreatmentcostsoverthelifetimeofvaccinatedcohorts.Thebroadereconomicandsocialvalueofvaccinationfrom20012020isworth$820billionin73LMICs.Conclusion:Theimpactofimmunizationgoesbeyondhealth,preventingsignificantcostsandpotentiallyincreasingeconomicproductivityamongtheworld’spoorestcountries
AU  - Ozawa,S
AU  - Clark,S
AU  - Portnoy,A
AU  - Grewal,S
AU  - Stack,ML
AU  - Sinha,A
AU  - Mirelman,A
AU  - Franklin,H
AU  - Friberg,IK
AU  - Tam,Y
AU  - Walker,N
AU  - Clark,A
AU  - Ferrari,M
AU  - Suraratdecha,C
AU  - Sweet,S
AU  - Goldie,SJ
AU  - Garske,T
AU  - Li,M
AU  - Hansen,PM
AU  - Johnson,HL
AU  - Walker,D
DO  - 10.2471/BLT.16.178475
EP  - 638
PY  - 2020///
SN  - 1564-0604
SP  - 629
TI  - Economic impact of vaccination against 10 vaccinepreventable diseases across 73 low and middleincome countries supported by Gavi, 20012020
T2  - Bulletin of the World Health Organization
UR  - http://dx.doi.org/10.2471/BLT.16.178475
UR  - https://www.who.int/bulletin/volumes/95/9/16-178475.pdf
UR  - http://hdl.handle.net/10044/1/48955
VL  - 95
ER  -
Download